[1]
G. Rodrigues, X. Yao, D. A. Loblaw, M. Brundage, and J. L. Chin, “Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer”, CUAJ, vol. 7, no. 5-6, pp. e411–6, Jun. 2013.